Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CABA
Cabaletta Bio, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$1.92
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$325.53M
RECENT INSIDER TRADES
2026-01-21
· Tomasello Shawn
(Director)
· BUY
2026-01-21
· Binder Gwendolyn
(President, Science & Tech.)
· BUY
2026-01-21
· Simon Mark
(Director)
· BUY
2026-01-21
· Gavel Steve
(Chief Commercial Officer)
· BUY
2026-01-21
· Nichtberger Steven
(President & CEO)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
146
Shares held
168,263,806
Value
$463.72M
Percent of shares outstanding
99.24%
As of quarter end
2026-06-30
RECENT NEWS
CABA: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cabaletta Bio presents at Morgan Stanley healthcare conference
Cabaletta Bio presents at Morgan Stanley conference on safety and scale
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS